HeartCore Diversifies Amid Revenue Contraction, Worsening Operating Losses (NASDAQ:HTCR)
HeartCore Enterprises reported Q2 '22 results. Given a slowing economic environment, loss of focus, increasing operating losses, & little management communication, my HTCR's outlook is Sell.